TNXP · Company research
Tonix Pharmaceuticals Holding Corp. (TNXP): Valuation Analysis
Available valuation snapshots and ratios; unavailable metrics remain blank.
RESEARCH CONTEXT
Understand the numbers
Available valuation snapshots and ratios; unavailable metrics remain blank. Use period, currency, units and source fields when interpreting values.
1records availableHealthcare
Valuation Analysis data
Database-backed records only
| valuation date | price | market cap | enterprise value | pe | forward pe | peg | price sales | price book | price fcf |
|---|---|---|---|---|---|---|---|---|---|
| Oct 8, 2026 | 7.695 | $132,273,553.6 | -53196446.40 | — | — | — | — | 0.58235141610569832304 | — |
Informational research only, not financial advice. Forecasts are uncertain and can be wrong.